Autoantibodies to endostatin in patients with breast cancer: Correlation to endostatin levels and clinical outcome

British Journal of Cancer

Volumn 94, Issue 7, 2006, Pages 1066-1070

  Bachelot, T ^a   Ratel, D ^b   Menetrier Caux, C ^a   Wion, D ^b   Blay, J Y ^a   Berger, F ^b  

^a CENTRE LÉON BÉRARD   (France)

^b HÔPITAL MICHALLON   (France)

Author keywords

Autoantibodies; Collagen xviii; Endostatin

Indexed keywords

AUTOANTIBODY; ENDOSTATIN; POLYPEPTIDE; RECOMBINANT HUMAN ENDOSTATIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; METASTASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

EID: 33645751986     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603037     Document Type: Article

References (18)

1. Bono P, Teerenhovi L, Joensuu H (2003) Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma. Cancer 97: 2767-2775, doi:10.1002/cncr.11399
2. Boon T, Old LJ (1997) Cancer tumor antigens. Curr Opin Immunol 9: 681-683
3. Brooks PC, Stromblad S, Klemke R, Visscher D, Sarkar FH, Cheresh DA (1995) Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 96: 1815-1822
4. Feldman AL, Alexander Jr HR, Yang JC, Linehan WM, Eyler RA, Miller MS, Steinberg SM, Libutti SK (2002) Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma. Cancer 95: 1637-1643, doi:10.1002/cncr.10845
5. Feldman AL, Pak H, Yang JC, Alexander Jr HR, Libutti SK (2001) Serum endostatin levels are elevated in patients with soft tissue sarcoma. Cancer 91: 1525-1529, doi:10.1002/1097-0142(20010415)91:8 〈 1525::AIDCNCR1161 〉 3.0.CO;2-P
6. Guenther U, Herbst H, Bauer M, Isbert C, Buhr HJ, Riecken EO, !QJ;Schuppan D (2001) Collagen type XVIII/endostatin is differentially expressed in primary and metastatic colorectal cancers and ovarian carcinomas. Br J Cancer 85: 1540-1545, doi:10.1054/bjoc.2001.2143
7. Hangai M, Kitaya N, Xu J, Chan CK, Kim JJ, Werb Z, Ryan SJ, Brooks PC (2002) Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis. Am J Pathol 161: 1429-1437
8. Muragaki Y, Timmons S, Griffith CM, Oh SP, Fadel B, Quertermous T, Olsen BR (1995) Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. Proc Natl Acad Sci USA 92: 8763-8767
9. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285
10. Ratel D, Nasser V, Dupre I, Benabid AL, Berger F (2000) Antibodies to endostatin in a multifocal glioblastoma patient. Lancet 356: 1656-1657, doi:10.1016/S0140-6736(00)03164-0
11. Ray-Coquard I, Ghesquiere H, Bachelot T, Borg C, Biron P, Sebban C, LeCesne A, Chauvin F, Blay JY (2001) Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas. Br J Cancer 85: 816-822
12. Sasaki T, Hohenester E, Timpl R (2002) Structure and function of collagen-derived endostatin inhibitors of angiogenesis. IUBMB Life 53: 77-84
13. Soussi T (2000) p53 Antibodies in the sera of patients with various types of cancer: a review. Cancer Res 60: 1777-1788
14. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW (2000) Genes expressed in human tumor endothelium. Science 289: 1197-1202, doi:10.1126/science.289. 5482.1197
15. Thomas JP, Arzoomanian RZ, Alberti D, Marnocha R, Lee F, Friedl A, Tutsch K, Dresen A, Geiger P, Pluda J, Fogler W, Schiller JH, Wilding G (2003) Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors. J Clin Oncol 21: 223-231
16. Treilleux I, Blay JY, Bendriss-Vermare N, Ray-Coquard I, Bachelot T, Guastalla JP, Bremond A, Goddard S, Pin JJ, Barthelemy-Dubois C, Lebecque S (2004) Dendritic cell infiltration and prognosis of early stage breast cancer. Clin Cancer Res 10: 7466-7474
17. von Mensdorff-Pouilly S, Verstraeten AA, Kenemans P, Snijdewint FG, Kok A, Van Kamp GJ, Paul MA, van Diest PJ, Meijer S, Hilgers J (2000) Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin. J Clin Oncol 18: 574-583
18. Xu J, Rodriguez D, Petitclerc E, Kim JJ, Hangai M, Moon YS, Davis GE, Brooks PC (2001) Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol 154: 1069-1079, doi:10.1083/jcb.200103111